Dyne Therapeutics Inc (NASDAQ:DYN)
| 14.78 Delayed Data As of 3:38pm ET |  +0.14 / +0.96%Today’s Change | 4.30 Today|||52-Week Range 15.63 | +27.52% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Atlas Venture Life Science Advisors Llc |  Buy | 12/12/2022 | 934,581 | $10.70 | $10.0M | +25.32% |
Atlas Venture Life Science Advisors Llc Director | Buy | 12/12/2022 | 934,581 | $10.70 | $10.0M | +25.32% |
Brumm Joshua T Director |  Sale | 10/10/2022 | 195,800 | $12.46 | $2.4M | +15.60% |
Mcneill Jonathan /dyne/ Corporate Officer | Sale | 1/09/2023 | 30,150 | $11.57 | $348.8K | +27.51% |
Brumm Joshua T Director | Buy | 10/10/2022 | 195,800 | $1.03 | $201.7K | +15.60% |
Brumm Joshua T Director | Sale | 10/07/2022 | 14,200 | $13.37 | $189.9K | +14.78% |
Brumm Joshua T Director | Sale | 9/20/2022 | 11,836 | $13.70 | $162.2K | +5.95% |
Mcneill Jonathan /dyne/ Corporate Officer | Sale | 1/18/2023 | 10,000 | $14.03 | $140.3K | +5.57% |
Brumm Joshua T Director | Sale | 7/06/2022 | 10,963 | $8.24 | $90.3K | +77.40% |
Brumm Joshua T Director | Sale | 9/15/2022 | 3,480 | $14.05 | $48.9K | +4.29% |
Page of 5